Search Results - Miravitlles, M

  • Showing 1 - 12 results of 12
Refine Results
  1. 1
    Actualización de las recomendaciones ALAT sobre la neumonía adquirida en la comunidad

    Actualización de las recomendaciones ALAT sobre la neumonía adquirida en la comunidad by Miravitlles, M.

    Published 2004
    Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Costes directos de la bronquitis crónica en atención primaria. Análisis de un estudio prospectivo

    Costes directos de la bronquitis crónica en atención primaria. Análisis de un estudio prospectivo by Miravitlles, M.

    Published 2001
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients?

    Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients? by Blasi, F., Canonica, G. W., Miravitlles, M.

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Erratum to: Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients?

    Erratum to: Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients? by Blasi, F., Canonica, G. W., Miravitlles, M.

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD

    Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD by Brusasco, V, Hodder, R, Miravitlles, M, Korducki, L, Towse, L, Kesten, S

    Published 2003
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Health outcomes following treatment for 6 months with once daily tiotropium compared with twice daily salmeterol in patients with COPD

    Health outcomes following treatment for 6 months with once daily tiotropium compared with twice daily salmeterol in patients with COPD by Brusasco, V, Hodder, R, Miravitlles, M, Korducki, L, Towse, L, Kesten, S

    Published 2006
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    Alpha‐1‐antitrypsin deficiency: optimal therapeutic regimen based on population pharmacokinetics

    Alpha‐1‐antitrypsin deficiency: optimal therapeutic regimen based on population pharmacokinetics by Soy, D, de la Roza, C, Lara, B, Esquinas, C, Torres, A, Miravitlles, M

    Published 2006
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Characterization of specific immunoglobulin G (IgG) and its subclasses (IgG1 and IgG2) against the 23-valent pneumococcal vaccine in a healthy adult population: proposal for response criteria.

    Characterization of specific immunoglobulin G (IgG) and its subclasses (IgG1 and IgG2) against the 23-valent pneumococcal vaccine in a healthy adult population: proposal for respon... by Rodrigo, M J, Miravitlles, M, Cruz, M J, de Gracia, J, Vendrell, M, Pascual, C, Morell, F

    Published 1997
    Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    Screening for polymorphisms in exon 5 of the glutathione S-transferase Pl gene

    Screening for polymorphisms in exon 5 of the glutathione S-transferase Pl gene by RODRIGUEZ-FRIAS, F., GONZALEZ, C., COSTA, X., CAMPOS, F., COTRINA, M., JARDI, R., MIRAVITLLES, M., VIDAL, R., ISHII, T., TERAMOTO, S., MATSUSE, T.

    Published 2000
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study

    Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study by Miravitlles, M, Ferrer, M, Pont, A, Zalacain, R, Alvarez-Sala, J, Masa, F, Verea, H, Murio, C, Ros, F, Vidal, R

    Published 2004
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease: a Spanish National Healthcare System perspective

    Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease:... by Driessen, M. T., Whalen, J., Seewoodharry Buguth, B., Vallejo-Aparicio, L. A., Naya, I. P., Asukai, Y., Alcázar-Navarrete, B., Miravitlles, M., García-Río, F., Risebrough, N. A.

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    Correction to: Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease: a Spanish National Healthcare System perspective

    Correction to: Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulm... by Driessen, M. T., Whalen, J., Buguth, B. Seewoodharry, Vallejo-Aparicio, L. A., Naya, I. P., Asukai, Y., Alcázar-Navarrete, B., Miravitlles, M., García-Río, F., Risebrough, N. A.

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: